SELECTIVE INHIBITORS OF PLACENTAL STEROID AROMATASE

NIH RePORTER · NIH · R01 · $166,362 · view on reporter.nih.gov ↗

Abstract

The objectives of this proposal include the design, synthesis an devaluation of specific inhibitors of human placental aromatase (estrogen synthetase). These inhibitors include enzyme-generated irreversible inhibitors and also competitive reversible inhibitors. Specific inhibitors of human biosynthesis in placental tissue and in other tissues. They may also be of value in the study and treatment of estrogen-dependent tumors, and in studying the role played by peripheral aromatization of androgen in male endocrinology. Mechanistic studies with these inhibitors should be of interest in further examination of the mechanism of action of aromatase. Covalent labeling of purified enzyme by radiolabeled inhibitors may provide valuable information about the enzyme's active site. A chemical model for aromatase has been developed, and this model will be evaluated in terms of the enzymatic process's stereochemical and kinetic behavior.

Key facts

NIH application ID
2196846
Project number
5R01HD011840-15
Recipient
JOHNS HOPKINS UNIVERSITY
SAM.gov UEI
FTMTDMBR29C7
Principal Investigator
CECIL H ROBINSON
Activity code
R01
Funding institute
NIH
Fiscal year
1993
Award amount
$166,362
Award type
5
Project period
1978-09-01 → 1995-05-31